Sotera Health Company Common Stock (SHC) — Analysis Summary
Sotera Health Company Common Stock (SHC) has a market cap of $5.56B with year-over-year revenue growth of +5.7%. Net margin stands at 6.7%. The stock trades at a P/E ratio of 34.0.
Key Takeaways
- Revenue changed +5.7% year-over-year
- Net margin of 6.7%
- P/E ratio of 34.0
Compared to other companies in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector, SHC posted revenue growth of +5.7% and trades at a P/E of 34.0.
Sotera Health Company Common Stock (SHC)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsWatch List
Some caution signals are active and should be weighed alongside the valuation work.
Debt/EBITDA at 5.8x — elevated leverage
D/E at 3.2x — high financial leverage
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Sector
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Employees
3,000
Headquarters
BROADVIEW HEIGHTS, OH
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.